Wednesday, July 17, 2019
Home Tags Akebia Therapeutics

Topic: Akebia Therapeutics

Current Performance: Akebia Therapeutics (NASDAQ: AKBA)

Akebia Therapeutics trades as part of the biotechnology industry and trades as part of the healthcare sector. The company CEO is John P. Butler. Akebia Therapeutics Inc is a biopharmaceutical company. It focuses...

Stock to Watch: Akebia Therapeutics (NASDAQ: AKBA)

Akebia Therapeutics trades as part of the healthcare sector and is in the biotechnology industry. The company CEO is John P. Butler. Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the...

Stock in the Spotlight: Akebia Therapeutics (NASDAQ: AKBA)

Akebia Therapeutics is part of the healthcare sector and is in the biotechnology industry. The company CEO is John P. Butler. Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and...

Recent Performance: Akebia Therapeutics (NASDAQ: AKBA)

Akebia Therapeutics is in the biotechnology industry and is in the healthcare sector. The company CEO is John P. Butler. Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and...

Recent Fundamentals: Akebia Therapeutics (NASDAQ: AKBA)

Akebia Therapeutics is part of the biotechnology industry and is part of the healthcare sector. The company CEO is John P. Butler. Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the...

Present Valuation: Akebia Therapeutics (NASDAQ: AKBA)

Akebia Therapeutics trades as part of the healthcare sector and is in the biotechnology industry. The company CEO is John P. Butler. Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the...

Long or Short: Akebia Therapeutics (NASDAQ: AKBA)

Akebia Therapeutics trades as part of the biotechnology industry and is in the healthcare sector. The company CEO is John P. Butler. Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the...

Latest News